The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Chasing Life with Dr. Sanjay Gupta
See all episodes →
Should You Give AI Your Medical Records? Sanjay Did.
Is AI Rewiring Your Kid’s Brain?
Revisiting: Exploring the Brain with 10-year-old 'Sean the Science Kid'
Similar episodes from other shows
More like Chasing Life with Dr. Sanjay Gupta →
Ozempic & Weight Loss Drugs: Game Changers or Health Hazards?
Understanding the Truth About Obesity and Weight Loss Drugs with Johann Hari
Here's How the New Weight Loss Drugs Could Change Everything
Ozempic’s Unknowns
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.